Trial intelligence / Profile preview

Pantoprazole interaction with mycophenolic acid in kidney and liver transplant recipients

ACTRN12611000316909Phase 4Not yet recruiting

Sponsor
Department of Health
Start
Jun 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of pantoprazole, sponsored by Department of Health. Primary endpoint: Dose-normalized mycophenolic acid and MPA-glucuronide area under the curve. Planned start Jun 2011; status: not yet recruiting.

02

Drugs

pantoprazole

Beyond the preview

Go deeper on ACTRN12611000316909.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12611000316909.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call